News

Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Weeks later, thousands of health workers are unemployed, HIV services are collapsing and the government hasn’t filled the gap ...
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.
Dr. Mark Dybul addresses a Senate hearing on global health issues in 2015. He was an architect of PEPFAR, the program created by President George W. Bush to stop the spread of AIDS. Programs like ...
Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in jeopardy as Congress reviews the Trump administration's funding rescission memo.